We are live on ! Find out more
OBIO icon

Orchestra BioMed
OBIO

54 hedge funds and large institutions have $77M invested in Orchestra BioMed in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

271% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 7

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

13% more funds holding

Funds holding: 48 → 54 (+6)

0.35% more ownership

Funds ownership: 50.29% → 50.65% (+0.35%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

21% less capital invested

Capital invested by funds: $97.8M → $77M (-$20.8M)

Holders
54
Holders Change
+6
Holders Change %
+12.5%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
26
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$207K
2
BlackRock
BlackRock
New York
+$196K
3
Millennium Management
Millennium Management
New York
+$116K
4
Goldman Sachs
Goldman Sachs
New York
+$108K
5
State Street
State Street
Massachusetts
+$97.2K

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$137K
2
Jane Street
Jane Street
New York
-$98K
3
SIA
SkyView Investment Advisors
New Jersey
-$63K
4
Morgan Stanley
Morgan Stanley
New York
-$42.6K
5
Citadel Advisors
Citadel Advisors
Florida
-$42.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$86.1K +$116K +21,513 New
Citigroup
27
Citigroup
New York
$77K +$12.9K +2,397 +14%
AFG
28
ABLE Financial Group
Arizona
$53.6K – – –
Mirae Asset Global ETFs Holdings
29
Mirae Asset Global ETFs Holdings
Hong Kong
$53.2K +$3.27K +608 +5%
Wells Fargo
30
Wells Fargo
California
$52.6K +$21.4K +3,992 +44%
SG Americas Securities
31
SG Americas Securities
New York
$51K +$14.2K +2,642 +26%
Citadel Advisors
32
Citadel Advisors
Florida
$49.1K -$42.1K -7,836 -39%
CF
33
Corebridge Financial
Texas
$48.8K -$1.16K -215 -2%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$48.7K +$65.4K +12,169 New
Deutsche Bank
35
Deutsche Bank
Germany
$48.3K – – –
IIM
36
INTECH Investment Management
Florida
$42K +$56.4K +10,491 New
SEI Investments
37
SEI Investments
Pennsylvania
$41.2K – – –
PFSRSONJ
38
Police & Firemen's Retirement System of New Jersey
New Jersey
$18.7K +$25.1K +4,671 New
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$17.8K +$23.9K +4,458 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$16K +$6.72K +1,251 +44%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$14.5K – – –
TRCT
42
Tower Research Capital (TRC)
New York
$9.29K +$2.19K +407 +21%
Legal & General Group
43
Legal & General Group
United Kingdom
$8.89K – – –
HI
44
Harbour Investments
Wisconsin
$7.95K +$10.7K +1,988 New
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$7.57K +$1.13K +210 +12%
AIP
46
Ameritas Investment Partners
Nebraska
$5.58K – – –
Fidelity Investments
47
Fidelity Investments
Massachusetts
$4.03K -$10K -1,868 -65%
AB
48
Amalgamated Bank
New York
$2K – – –
SCM
49
Sterling Capital Management
North Carolina
$1.85K +$2.2K +409 +772%
Russell Investments Group
50
Russell Investments Group
United Kingdom
$500 -$1.06K -198 -61%
1
2
3

OBIO Hedge Fund Activity: Q4 2024 in Review

54 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Orchestra BioMed (OBIO) for Q4 2024, worth a combined $77M — down 21% from $97.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new OBIO positions and 4 closed out — a net gain of 6 holders — while 26 added to existing stakes and 7 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $207K. The largest seller was T. Rowe Price Associates, cutting an estimated $137K.

  • 54 institutional investors held Orchestra BioMed (OBIO) as of Q4 2024, up from 48 in Q3 2024.
  • Funds reported $77M of Orchestra BioMed stock for Q4 2024, down 21% quarter-over-quarter.
  • 10 funds opened new Orchestra BioMed positions in Q4 2024 and 4 closed out, a net change of +6 holders.
  • The largest Orchestra BioMed buyer in Q4 2024 was JP Morgan Chase, an estimated $207K added.
  • The largest Orchestra BioMed seller in Q4 2024 was T. Rowe Price Associates, an estimated $137K sold.

Based on aggregated 13F filings for Q4 2024.